Literature DB >> 31236746

Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.

Yue Sun1, Zhihong Wang1, Huihui Chi1, Qiongyi Hu1, Junna Ye1, Honglei Liu1, Xiaobing Cheng1, Hui Shi1, Zhuochao Zhou1, Jialin Teng1, Chengde Yang2, Yutong Su3.   

Abstract

To evaluate the serum levels of the anti-inflammatory cytokine interleukin-10 (IL-10) in patients with adult-onset Still's disease (AOSD), a rare, systemic, and multigenic inflammatory disease. The serum levels of IL-10, IL-1β, IL-6, IL-18, and TNF-α were examined by electrochemiluminescence assay. The serum levels of IL-10 were higher in AOSD patients than in healthy controls and positively correlated with systemic score, erythrocyte sedimentation rate (ESR), C-reactive protein level (CRP), ferritin, and inflammatory cytokine (IL-1β, IL-6, IL-18, and TNF-α) levels. Moreover, the levels of IL-10 were significantly higher in AOSD patients who had fever, sore throat, rash, lymphadenopathy, splenomegaly, pneumonia, and arthralgia than in patients who did not. IL-10 was increased in AOSD patients and correlated with disease activity. KEY POINTS: • In this manuscript, we confirmed the elevated serum levels of the anti-inflammatory cytokine IL-10 in AOSD patients, which was previously poorly defined. • We revealed for the first time that the levels of IL-10 were correlated with disease activity and inflammatory cytokine levels in AOSD.

Entities:  

Keywords:  Adult-onset Still’s disease; Disease activity; IL-10; Inflammation

Year:  2019        PMID: 31236746     DOI: 10.1007/s10067-019-04642-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

Review 1.  Adult-onset Still's disease.

Authors:  Mathieu Gerfaud-Valentin; Yvan Jamilloux; Jean Iwaz; Pascal Sève
Journal:  Autoimmun Rev       Date:  2014-03-19       Impact factor: 9.754

2.  IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration.

Authors:  Upasana Kulkarni; Christian M Karsten; Thomas Kohler; Sven Hammerschmidt; Kurt Bommert; Benjamin Tiburzy; Lingzhang Meng; Lara Thieme; Andreas Recke; Ralf J Ludwig; Karolin Pollok; Kathrin Kalies; Bjarne Bogen; Martin Boettcher; Thomas Kamradt; Anja E Hauser; Christian Langer; Markus Huber-Lang; Fred D Finkelman; Jörg Köhl; David M Wong; Rudolf Armin Manz
Journal:  J Allergy Clin Immunol       Date:  2015-12-02       Impact factor: 10.793

3.  Successful treatment with plasma exchange in adult-onset Still's disease with hyper-IL-18-naemia and hyperallergic state.

Authors:  Tomoki Ito; Yoshio Ozaki; Keiko Shimamoto; Hideki Amuro; Tsutomu Tanijiri; Takashi Yokoi; Yonsu Son; Kenichirou Tajima; Shirou Fukuhara
Journal:  Mod Rheumatol       Date:  2008-04-29       Impact factor: 3.023

Review 4.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

5.  Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Fang-Ju Lin; Tsu-Yi Hsieh
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

Review 6.  A comprehensive review on adult onset Still's disease.

Authors:  Roberto Giacomelli; Piero Ruscitti; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2018-08-01       Impact factor: 7.094

7.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

9.  Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.

Authors:  Huihui Chi; Dongzhou Liu; Yue Sun; Qiongyi Hu; Honglei Liu; Xiaobing Cheng; Junna Ye; Hui Shi; Yufeng Yin; Mengru Liu; Xinyao Wu; Zhuochao Zhou; Jialin Teng; Chengde Yang; Yutong Su
Journal:  Arthritis Res Ther       Date:  2018-03-22       Impact factor: 5.156

Review 10.  From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.

Authors:  Jacques Banchereau; Virginia Pascual; Anne O'Garra
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

View more
  8 in total

1.  Periplaneta americana extract ameliorates dextran sulfate sodium-induced ulcerative colitis via immunoregulatory and PI3K/AKT/NF-κB signaling pathways.

Authors:  Lianli Ni; Qian Lu; Miao Tang; Lu Tao; Hairong Zhao; Chenggui Zhang; Yun Yu; Xiumei Wu; Heng Liu; Ri Cui
Journal:  Inflammopharmacology       Date:  2022-03-18       Impact factor: 4.473

Review 2.  Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.

Authors:  Meng-Yan Wang; Jin-Chao Jia; Cheng-De Yang; Qiong-Yi Hu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

3.  Adult-onset Still's disease evolving with multiple organ failure and death: A case report and review of the literature.

Authors:  Zhong-Bin Han; Ju Wu; Jing Liu; He-Ming Li; Kai Guo; Tong Sun
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

4.  The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juvenile Idiopathic Arthritis Patients.

Authors:  Yu Peng; Xiaohui Liu; Zhao Duan; Junkai Duan; Yulan Zhou
Journal:  Mediators Inflamm       Date:  2021-03-22       Impact factor: 4.711

5.  B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's Disease.

Authors:  Olfa Maghrebi; Meriam Belghith; Cyrine Jeridi; Amine Rachdi; Fatma Nabli Fatnassi; Zakaria Saied; Samir Belal; Samia Ben Sassi; Mohamed-Ridha Barbouche
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

Review 6.  Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

Authors:  Shijia Rao; Lemuel Shui-Lun Tsang; Ming Zhao; Wei Shi; Qianjin Lu
Journal:  Front Med (Lausanne)       Date:  2022-08-22

7.  Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.

Authors:  Po-Ku Chen; Joung-Liang Lan; Ju-Pi Li; Ching-Kun Chang; Shih-Hsin Chang; Po-Hao Huang; Kai-Jieh Yeo; Der-Yuan Chen
Journal:  Clin Rheumatol       Date:  2020-01-20       Impact factor: 2.980

8.  Risk factors associated with relapse of adult-onset Still disease in Korean patients.

Authors:  Ji-Hyoun Kang
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.